GNNSF
Price
$2.25
Change
-$0.17 (-7.02%)
Updated
Sep 17 closing price
Capitalization
4.6B
SCNI
Price
$1.42
Change
+$0.07 (+5.19%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
4.26M
Interact to see
Advertisement

GNNSF vs SCNI

Header iconGNNSF vs SCNI Comparison
Open Charts GNNSF vs SCNIBanner chart's image
Genscript Biotech
Price$2.25
Change-$0.17 (-7.02%)
Volume$1.2K
Capitalization4.6B
Scinai Immunotherapeutics
Price$1.42
Change+$0.07 (+5.19%)
Volume$188
Capitalization4.26M
GNNSF vs SCNI Comparison Chart in %
Loading...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNNSF vs. SCNI commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNNSF is a Hold and SCNI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (GNNSF: $2.25 vs. SCNI: $1.35)
Brand notoriety: GNNSF and SCNI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNNSF: 67% vs. SCNI: 10%
Market capitalization -- GNNSF: $4.6B vs. SCNI: $4.26M
GNNSF [@Biotechnology] is valued at $4.6B. SCNI’s [@Biotechnology] market capitalization is $4.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNNSF’s FA Score shows that 0 FA rating(s) are green whileSCNI’s FA Score has 2 green FA rating(s).

  • GNNSF’s FA Score: 0 green, 5 red.
  • SCNI’s FA Score: 2 green, 3 red.
According to our system of comparison, both GNNSF and SCNI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNNSF’s TA Score shows that 1 TA indicator(s) are bullish while SCNI’s TA Score has 3 bullish TA indicator(s).

  • GNNSF’s TA Score: 1 bullish, 3 bearish.
  • SCNI’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, SCNI is a better buy in the short-term than GNNSF.

Price Growth

GNNSF (@Biotechnology) experienced а -7.02% price change this week, while SCNI (@Biotechnology) price change was -14.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNNSF($4.6B) has a higher market cap than SCNI($4.26M). GNNSF YTD gains are higher at: 77.165 vs. SCNI (-59.641).
GNNSFSCNIGNNSF / SCNI
Capitalization4.6B4.26M108,038%
EBITDAN/A8.11M-
Gain YTD77.165-59.641-129%
P/E RatioN/A0.34-
RevenueN/A1.15M-
Total CashN/A989K-
Total DebtN/A2.36M-
FUNDAMENTALS RATINGS
GNNSF vs SCNI: Fundamental Ratings
GNNSF
SCNI
OUTLOOK RATING
1..100
965
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
987
PRICE GROWTH RATING
1..100
4594
P/E GROWTH RATING
1..100
4099
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCNI's Valuation (23) in the Pharmaceuticals Major industry is significantly better than the same rating for GNNSF (93) in the null industry. This means that SCNI’s stock grew significantly faster than GNNSF’s over the last 12 months.

GNNSF's Profit vs Risk Rating (95) in the null industry is in the same range as SCNI (100) in the Pharmaceuticals Major industry. This means that GNNSF’s stock grew similarly to SCNI’s over the last 12 months.

SCNI's SMR Rating (7) in the Pharmaceuticals Major industry is significantly better than the same rating for GNNSF (98) in the null industry. This means that SCNI’s stock grew significantly faster than GNNSF’s over the last 12 months.

GNNSF's Price Growth Rating (45) in the null industry is somewhat better than the same rating for SCNI (94) in the Pharmaceuticals Major industry. This means that GNNSF’s stock grew somewhat faster than SCNI’s over the last 12 months.

GNNSF's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for SCNI (99) in the Pharmaceuticals Major industry. This means that GNNSF’s stock grew somewhat faster than SCNI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNNSFSCNI
RSI
ODDS (%)
Bearish Trend 2 days ago
63%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMTE1.140.01
+0.88%
Integrated Media Technology Limited
SFM119.38-0.21
-0.18%
Sprouts Farmers Market
STC74.07-0.29
-0.39%
Stewart Information Services Corp
NCMI4.78-0.02
-0.42%
National CineMedia
INCR1.45-0.03
-2.03%
Intercure Ltd

GNNSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNNSF has been loosely correlated with SILO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GNNSF jumps, then SILO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
N/A
SILO - GNNSF
42%
Loosely correlated
+4.08%
SCNI - GNNSF
26%
Poorly correlated
-6.90%
CORT - GNNSF
25%
Poorly correlated
+4.15%
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
More

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with NBY. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then NBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-6.90%
NBY - SCNI
88%
Closely correlated
+1.42%
NCNA - SCNI
88%
Closely correlated
-2.99%
TAOX - SCNI
88%
Closely correlated
-2.90%
RNAC - SCNI
86%
Closely correlated
-2.29%
AGEN - SCNI
86%
Closely correlated
-3.48%
More